Pulse Biosciences Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Pulse Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $30.67. The average 1-year stock price forecast is 19.80% higher than the current stock price, while the lowest is $30 (+17.19%) and the highest is $32 (+25.00%).

Price Target: $30.67 (+19.80%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$30.67	$30	$32
Change	+17.19%	+19.80%	+17.19%	+25.00%

Analyst Ratings

The average analyst rating for Pulse Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
William Plovanic Canaccord Genuity	Canaccord Genuity	Buy Initiates $32	Buy	Initiates	$32	+25.00%	Jun 4, 2026
Anthony Petrone Mizuho Securities	Mizuho Securities	Buy Maintains $31 → $30	Buy	Maintains	$31 → $30	+17.19%	Apr 13, 2026
Suraj Kalia Oppenheimer	Oppenheimer	Buy Reiterates $22 → $30	Buy	Reiterates	$22 → $30	+17.19%	Feb 20, 2026

Financial Forecast

Revenue This Year

2.63M

from 350.00K

652.38%

from 350.00K

Revenue Next Year

8.87M

from 2.63M

236.71%

from 2.63M

EPS This Year

-1.07

from -0.75

EPS Next Year

-1.09

from -1.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.42M	700.00K	-	-	350.00K	2.63M
Revenue Growth	-	-50.64%	-	-	-	652.38%
Gross Profit	-550.00K	-11.24M	-	-	-189.00K	273.43K
Gross Margin	-38.79%	-1,606.29%	-	-	-54.00%	10.38%
Operating Income	-63.01M	-58.06M	-43.57M	-56.26M	-76.94M	-86.67M
Net Income	-63.66M	-58.51M	-42.21M	-53.59M	-72.78M	-91.42M
EPS	-	-	-	-	-0.75	-1.07
Free Cash Flow	-30.40M	-26.84M	-18.13M	-17.92M	-29.52M	-68.00M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	3.6M
Avg	2.6M
Low	1.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	928.6%
Avg	652.4%
Low	357.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-1.07
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-